Pancreatic Cancer Research

ResearcherNebraska Medical CenterNo recent work listed

Dipakkumar R. Prajapati

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8954-890X; OpenAlex author ID A5091754230. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
34
Papers, trials and grants by year

2020: 3 papers · 2021: 3 papers · 2022: 1 paper · 2023: 1 paper

Papers 8

  1. Small molecule antagonist of CXCR2 and CXCR1 inhibits tumor growth, angiogenesis, and metastasis in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2023.216185↗
  2. Differential expression profile of CXC-receptor-2 ligands as potential biomarkers in pancreatic ductal adenocarcinoma. Co-author PMID 35141005↗
  3. Host Cxcr2-Dependent Regulation of Pancreatic Cancer Growth, Angiogenesis, and Metastasis. Co-author DOI 10.1016/j.ajpath.2021.01.002↗
  4. Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41388-020-01518-2↗
  5. Plexin-B3 Regulates Cellular Motility, Invasiveness, and Metastasis in Pancreatic Cancer. First author DOI 10.3390/cancers13040818↗
  6. Stromal Modulation and Treatment of Metastatic Pancreatic Cancer with Local Intraperitoneal Triple miRNA/siRNA Nanotherapy. Co-author DOI 10.1021/acsnano.9b03978↗
  7. Global analysis of human glycosyltransferases reveals novel targets for pancreatic cancer pathogenesis. Co-author DOI 10.1038/s41416-020-0772-3↗
  8. CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Co-author DOI 10.1096/fj.201902990r↗

Closest collaborators

The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sugandha Saxena · 5 shared papers, 2020–2023 · strength 0.70
  2. Rakesh K. Singh · 5 shared papers, 2020–2023 · strength 0.66
  3. Surinder K. Batra · 5 shared papers, 2020–2023 · strength 0.65
  4. Abhilasha Purohit · 4 shared papers, 2020–2023 · strength 0.58
  5. Satyanarayana Rachagani · 4 shared papers, 2020–2021 · strength 0.43
  6. Sushil Kumar K · 3 shared papers, 2020–2023 · strength 0.39
  7. Michael Anthony Hollingsworth · 3 shared papers, 2021–2022 · strength 0.36
  8. Paul M. Grandgenett · 3 shared papers, 2021–2022 · strength 0.36
  9. Caitlin Molczyk · 2 shared papers, 2022–2023 · strength 0.33
  10. Pranita Atri · 2 shared papers, 2021–2022 · strength 0.26
  11. Frank Leon · 2 shared papers, 2020–2021 · strength 0.20
  12. Rohitesh Gupta · 2 shared papers, 2020–2021 · strength 0.20
  13. Palanisamy Nallasamy · 2 shared papers, 2020–2021 · strength 0.20
  14. Seema Chugh · 2 shared papers, 2020–2021 · strength 0.20
  15. Rama Krishna Nimmakayala · 2 shared papers, 2020–2021 · strength 0.20
  16. Moorthy Palanimuthu Ponnusamy · 2 shared papers, 2020–2021 · strength 0.20
  17. Reegan Sturgeon · 1 shared paper, 2023 · strength 0.18
  18. Rakesh K. Singh · 1 shared paper, 2022 · strength 0.14
  19. Sukhwinder Kaur · 1 shared paper, 2022 · strength 0.14
  20. Saswati Karmakar · 1 shared paper, 2020 · strength 0.11
  21. Christopher M. Thompson · 1 shared paper, 2020 · strength 0.11
  22. Richard L. Sleightholm · 1 shared paper, 2020 · strength 0.10
  23. Mohammad I. Awaji · 1 shared paper, 2020 · strength 0.10
  24. Ying Xie · 1 shared paper, 2020 · strength 0.10
  25. Hang Yu · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.